Medicine and Dentistry
Health Care Cost
100%
Retina Dystrophy
61%
General Medicine
61%
Genetic Screening
40%
Shared Decision Making
40%
Irritable Bowel Syndrome
33%
Chronic Obstructive Pulmonary Disease
32%
Diabetes
30%
Pelvis
28%
Quality Adjusted Life Year
24%
Patient Experience
24%
Medication Error
24%
National Health Service
21%
Screening
20%
Breast Screening
20%
Nodular Melanoma
20%
Chemoradiotherapy
20%
Symptom
20%
Colorectal Cancer
20%
Pelvis Cancer
20%
Diagnostic Test
20%
Technology Assessment
20%
Medicines Management
20%
Randomized Clinical Trial
20%
Capillaroscopy
20%
Patient Population
20%
Genetic Counseling
20%
Whole Genome Sequencing
20%
Skin Cancer
20%
Care (Medicine)
20%
Health Care Management
20%
Self Concept
20%
Effect Size
20%
Social Health
20%
Psychological Well-Being
20%
Retinitis pigmentosa
20%
Arm
20%
Vein Insufficiency
20%
Endovascular Coiling
20%
Chronic Pain
20%
Diagnosis
17%
Cluster Randomized Trial
15%
Health Service
14%
Healthy Lifestyle
12%
Pelvic Radiotherapy
12%
Quality Improvement
10%
Jejunum Ulcer
10%
Loop Diuretic Agent
10%
Asthma
10%
ACE Inhibitor
10%
Nursing and Health Professions
Primary Medical Care
86%
Cost Effectiveness Analysis
73%
General Practice
65%
Self Care
47%
Information Technology
47%
Quality Adjusted Life Year
43%
Medicines Management
40%
Medication Error
33%
Shared Decision-Making
22%
Genetic Service
20%
Pilot Study
20%
Pharmacy
20%
Melanoma
20%
Vocational Rehabilitation
20%
Care Bundle
20%
Self Help
20%
Colorectal Cancer
20%
Chemoradiotherapy
20%
Symptom
20%
Feminization
20%
Clinical Effectiveness
20%
Skin Cancer
20%
Pelvis Cancer
20%
Pharmacy Student
20%
Retinitis pigmentosa
20%
Rheumatoid Arthritis
20%
Time Series Analysis
20%
Coil Embolization
20%
Vein Insufficiency
20%
Economic Analysis
20%
Chronic Pain
20%
Quality of Life
18%
Radiotherapy
16%
Incremental Cost-Effectiveness Ratio
14%
Health Care Cost
13%
Jejunum Ulcer
10%
Asthma
10%
Loop Diuretic Agent
10%
Dipeptidyl Carboxypeptidase Inhibitor
10%
Irritable Colon
10%
Health Service
10%
Malignant Neoplasm
9%
Obstructive Lung Disease
8%
Patient Population
8%
Treatment Outcome
7%
Cohort Analysis
6%
Epileptic Absence
6%
Hospital Pharmacy
6%
Community Pharmacist
6%
Practice Guideline
6%
